Sign In
Buy CMCO
Columbus McKinnon Earnings Calls
| Release date | Jun 04, 2026 |
| EPS estimate | $0.337 |
| EPS actual | $0.240 |
| EPS Surprise | -28.72% |
| Revenue estimate | 417.877M |
| Revenue actual | 437.829M |
| Revenue Surprise | 4.77% |
| Release date | Feb 09, 2026 |
| EPS estimate | $0.610 |
| EPS actual | $0.620 |
| EPS Surprise | 1.64% |
| Revenue estimate | 249.231M |
| Revenue actual | 258.655M |
| Revenue Surprise | 3.78% |
| Release date | Oct 30, 2025 |
| EPS estimate | $0.540 |
| EPS actual | $0.620 |
| EPS Surprise | 14.81% |
| Revenue estimate | 240.625M |
| Revenue actual | 261.047M |
| Revenue Surprise | 8.49% |
| Release date | Jul 29, 2026 |
| EPS estimate | $0.280 |
| EPS actual | - |
| Revenue estimate | 501.273M |
| Revenue actual | - |
| Expected change | +/- 9.11% |
Last 4 Quarters for Columbus McKinnon
Below you can see how CMCO performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Jul 29, 2026 |
| Price on release | - |
| EPS estimate | $0.280 |
| EPS actual | - |
| Date | Price |
|---|---|
| Jun 16, 2026 | $13.92 |
| Jun 17, 2026 | $13.98 |
| Jun 18, 2026 | $14.69 |
| Jun 22, 2026 | $14.55 |
| Jun 23, 2026 | $14.04 |
| Release date | Oct 30, 2025 |
| Price on release | $17.35 |
| EPS estimate | $0.540 |
| EPS actual | $0.620 |
| EPS surprise | 14.81% |
| Date | Price |
|---|---|
| Oct 24, 2025 | $15.75 |
| Oct 27, 2025 | $15.70 |
| Oct 28, 2025 | $15.40 |
| Oct 29, 2025 | $15.05 |
| Oct 30, 2025 | $17.35 |
| Oct 31, 2025 | $16.23 |
| Nov 03, 2025 | $16.01 |
| Nov 04, 2025 | $15.19 |
| Nov 05, 2025 | $15.80 |
| 4 days before | 10.16% |
| 4 days after | -8.93% |
| On release day | -6.46% |
| Change in period | 0.317% |
| Release date | Feb 09, 2026 |
| Price on release | $22.90 |
| EPS estimate | $0.610 |
| EPS actual | $0.620 |
| EPS surprise | 1.64% |
| Date | Price |
|---|---|
| Feb 03, 2026 | $21.07 |
| Feb 04, 2026 | $21.58 |
| Feb 05, 2026 | $21.00 |
| Feb 06, 2026 | $22.76 |
| Feb 09, 2026 | $22.90 |
| Feb 10, 2026 | $22.93 |
| Feb 11, 2026 | $23.27 |
| Feb 12, 2026 | $21.20 |
| Feb 13, 2026 | $20.33 |
| 4 days before | 8.69% |
| 4 days after | -11.22% |
| On release day | 0.131% |
| Change in period | -3.51% |
| Release date | Jun 04, 2026 |
| Price on release | $14.08 |
| EPS estimate | $0.337 |
| EPS actual | $0.240 |
| EPS surprise | -28.72% |
| Date | Price |
|---|---|
| May 29, 2026 | $15.96 |
| Jun 01, 2026 | $15.57 |
| Jun 02, 2026 | $15.83 |
| Jun 03, 2026 | $15.51 |
| Jun 04, 2026 | $14.08 |
| Jun 05, 2026 | $12.88 |
| Jun 08, 2026 | $12.46 |
| Jun 09, 2026 | $12.71 |
| Jun 10, 2026 | $12.12 |
| 4 days before | -11.78% |
| 4 days after | -13.92% |
| On release day | -8.52% |
| Change in period | -24.06% |
Columbus McKinnon Earnings Call Transcript Summary of Q1 2026
Columbus McKinnon reported Q1 FY2026 results roughly in line with expectations. Orders grew 2% year-over-year to $259M (backlog up 23% YoY to $360M), driven by project-related demand and strength in EMEA and targeted end markets (battery production, e-commerce, food & beverage, aerospace, defense, oil & gas, rail). Sales were down ~2% to $235.9M, with short-cycle weakness (tariff and Germany softness) offset partially by price increases and FX tailwind. Tariffs materially pressured gross profit (a $4.2M impact in Q1 and an expected ~$10M headwind to operating profit in H1), compressing adjusted gross margin to 34.3% (adjusted operating margin 7.8%). Management expects tariff cost neutrality by H2 FY2026 and margin neutrality by FY2027 as mitigation actions take effect. Adjusted EPS was $0.50 (GAAP loss per share $0.07); free cash flow was negative $21.4M due to seasonality and M&A/tariff/tax payments. The company reaffirmed full-year guidance (net sales flat to slightly up; adjusted EPS flat to slightly up) and remains on track for the Kito Crosby acquisition, targeting close by year-end (one remaining regulatory approval and an HSR second request in process). Pro forma leverage at close is now expected to be ~5.0x (vs. prior ~4.8x) primarily due to tariff impacts. CapEx guidance is ~$20–25M for the year.
